|
⚲
|
| Keyboard |
| Reich Kristian
✚
|
|
|---|---|
| CIK # | 0001920553 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001920553] | |
| 4 | [0001920553] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Reich Kristian | |
| MoonLake Immunotherapeutics |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
MoonLake Immunotherapeutics MLTX
Stock Option (Right to Buy) · derivative
|
2026-01-07 | Grant | 520,342 | $0.00 | |
|
MoonLake Immunotherapeutics MLTX
Common shares, par value CHF 0.10 per share, of MoonLake AG · derivative
|
2025-12-19 | Conversion | 1,052 | ||
|
MoonLake Immunotherapeutics MLTX
Class A ordinary shares, par value $0.0001 per share
|
2025-12-19 | Conversion | 35,389 | ||
|
MoonLake Immunotherapeutics MLTX
Class C ordinary shares, par value $0.0001 per share
|
2025-12-19 | Disposed to issuer | 35,389 | ||
|
MoonLake Immunotherapeutics MLTX
Class A ordinary shares, par value $0.0001 per share
|
2025-12-09 | Sell | 72,908 | $14.43 | 1,052,062 |
|
MoonLake Immunotherapeutics MLTX
Class A ordinary shares, par value $0.0001 per share
|
2025-12-08 | Sell | 130,000 | $15.08 | 1,960,400 |
|
MoonLake Immunotherapeutics MLTX
Stock Option (Right to Buy) · derivative
|
2025-02-27 | Grant | 139,273 | $0.00 | |
|
MoonLake Immunotherapeutics MLTX
Class A ordinary shares, par value $0.0001 per share
|
2025-01-20 | Conversion | 111,949 | ||
|
MoonLake Immunotherapeutics MLTX
Common shares, par value CHF 0.10 per share, of MoonLake AG · derivative
|
2025-01-20 | Conversion | 3,328 | ||
|
MoonLake Immunotherapeutics MLTX
Class C ordinary shares, par value $0.0001 per share
|
2025-01-20 | Disposed to issuer | 111,949 | ||
|
MoonLake Immunotherapeutics MLTX
Class A ordinary shares, par value $0.0001 per share
|
2024-02-28 | Sell | 28,090 | $55.00 | 1,544,950 |
|
MoonLake Immunotherapeutics MLTX
Class A ordinary shares, par value $0.0001 per share
|
2024-02-28 | Sell | 31,910 | $55.00 | 1,755,050 |
|
MoonLake Immunotherapeutics MLTX
Class A ordinary shares, par value $0.0001 per share
|
2024-02-27 | Sell | 29,431 | $55.00 | 1,618,705 |
|
MoonLake Immunotherapeutics MLTX
Class A ordinary shares, par value $0.0001 per share
|
2024-02-27 | Sell | 29,491 | $55.00 | 1,622,005 |
|
MoonLake Immunotherapeutics MLTX
Class A ordinary shares, par value $0.0001 per share
|
2024-02-21 | Sell | 509 | $55.31 | 28,153 |
|
MoonLake Immunotherapeutics MLTX
Class A ordinary shares, par value $0.0001 per share
|
2024-02-21 | Sell | 569 | $55.30 | 31,466 |
|
MoonLake Immunotherapeutics MLTX
Class A ordinary shares, par value $0.0001 per share
|
2024-02-20 | Sell | 10,000 | $57.45 | 574,500 |
|
MoonLake Immunotherapeutics MLTX
Class A ordinary shares, par value $0.0001 per share
|
2024-02-20 | Sell | 10,000 | $57.43 | 574,300 |
|
MoonLake Immunotherapeutics MLTX
Class A ordinary shares, par value $0.0001 per share
|
2024-02-16 | Sell | 10,000 | $60.15 | 601,500 |
|
MoonLake Immunotherapeutics MLTX
Class A ordinary shares, par value $0.0001 per share
|
2024-02-16 | Sell | 10,000 | $60.15 | 601,500 |
| showing 20 of 36 most recent transactions | |||||